Related Experiment Videos
[Continuous peritoneal dialysis in children]
Insights
Chronic peritoneal dialysis (CPD) in uremic children shows promising results, with the majority experiencing good linear growth and improved quality of life. This treatment modality offers an attractive option for pediatric end-stage renal disease management.
Area of Science:
- Pediatric Nephrology
- Renal Replacement Therapy
Context:
- Chronic peritoneal dialysis (CPD) is a vital treatment for pediatric end-stage renal disease.
- This study evaluates outcomes in children undergoing CPD since 1982.
Purpose:
- To assess the long-term efficacy and complications of CPD in a cohort of uremic children.
- To evaluate patient survival, transplant rates, and growth outcomes.
Summary:
- Thirty-two uremic children were treated with CPD (CCPD or CCPD).
- Outcomes included 31% alive with transplant, 50% awaiting transplant, 16% mortality, and 3% switched to hemodialysis.
- Common complications were peritonitis, catheter issues, and hernias, with good to excellent linear growth observed.
Impact:
- CPD demonstrates a favorable quality of life for pediatric patients with kidney failure.
- The findings support CPD as an effective and attractive renal replacement therapy in children.
Abstract:
Thirty-two uremic children were treated by chronic peritoneal dialysis (CPD) since February 1982. Fifteen chose chronic ambulatory peritoneal dialysis (CCPD) while the 17 others were treated by continuous cycle peritoneal dialysis (CCPD). To this day, 10 patients (31%) are alive with a functioning kidney transplant, 16 (50%) are still treated by CPD awaiting a transplant, 5 have died (16%) and one went back to hemodialysis (3%). Complication in ranking order were peritonitis, mechanical drainage problems of the catheter and hernias. Linear growth was from good to excellent in the majority of patients. Globally, CPD was found to be attractive mainly because it allows a good quality of life.